A study to assess the effect of Yava Mantha as a pathya in the management of Prameha (Type 2 Diabetes mellitus).

A single arm clinical study to evaluate the effect of Yava Mantha as a Pathya in the management of Prameha. - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058187

Enrollment

Registered

2023-10-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: A known Type -2 Diabetes Mellitus patient on treatment from 6 months showing symptoms of Prameha. Patient with fasting blood sugar >126 mg/dl -180mg/dl and post prandial blood sugar 200-250 mg/dl Patient having HbA1C >6.4mg/dl

Exclusion criteria

Exclusion criteria: Diabetes Mellitus Type-I and those who are under insulin therapy. Pregnant and lactating mothers. Patients with acute complications like Ketoacidosis and infections like gangrene. Patients with chronic complications like Nephropathy, Neuropathy and Retinopathy.

Design outcomes

Primary

Measure	Time frame
A clinical study to evaluate the effect of Yava Mantha in Prameha. The parameters of efficacy of Yava Mantha will be evaluate by observing the patient through subjective & objective criteria at regular intervals 0th,30th,60th,90th days follow up. The relief of sign & symptoms of Prameha will be analyzed with the help of Five point likert scale.Timepoint: The parameters of efficacy of Yava Mantha will be evaluate by observing the patient through subjective & objective criteria at regular intervals 0th,30th,60th,90th days follow up. The relief of sign & symptoms of Prameha will be analyzed with the help of Five point likert scale.	—

Measure

Time frame

A clinical study to evaluate the effect of Yava Mantha in Prameha. The parameters of efficacy of Yava Mantha will be evaluate by observing the patient through subjective & objective criteria at regular intervals 0th,30th,60th,90th days follow up. The relief of sign & symptoms of Prameha will be analyzed with the help of Five point likert scale.Timepoint: The parameters of efficacy of Yava Mantha will be evaluate by observing the patient through subjective & objective criteria at regular intervals 0th,30th,60th,90th days follow up. The relief of sign & symptoms of Prameha will be analyzed with the help of Five point likert scale.

—

Secondary

Measure	Time frame
The secondary outcome will be to explore & promote Krutanna Kalpana mention in Ayurveda Samhita.Timepoint: The Yava Mantha will be given for 90 days. Patient will be assessed on 0th,30th,60th,90th day of treatment. Total duration of study 90 days.	—

Countries

India

Contacts

Public ContactDrRoma Gangawane

MAMs Sumatibhai Shah Ayurveda Mahavidyalaya,Hadapsar,Pune.

roma.gangawane@gmail.com9822007402

Outcome results